Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Pa Shun International Holdings Limited ϵڦ਷ყછٰϞࠢʮ̡

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 574)

INSIDER INFORMATION

This announcement is made by Pa Shun International Holdings Limited (the "Company") under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) and pursuant to Rule 13.09(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

The board of directors (the "Board") of the Company announces that on 11 September 2020, it was made aware that a petition (the "Petition") was filed on 9 September 2020 by Mr. Feng Lihua (the "Petitioner") against the Company in the High Court of the Hong Kong Special Administrative Region (the "Court") for an order that the Company be wound up by the Court. The Petition was filed against the Company for the Company's failure to settle the interest payment in the sum of HK$650,000 due on 30 September 2019 in respect of the bond in the principal sum of HK$10 million issued to the Petitioner by the Company.

The Company is in the course of seeking legal advice on the matter. The Company will keep its shareholders and investors informed of any significant development of the Petition as and when appropriate.

Shareholders and/or potential investors of the Company are urged to exercise extreme caution when dealing in the securities of the Company.

By order of the Board

Pa Shun International Holdings Limited

Mr. Wu Guohua Non-Executive Director

Hong Kong, 14 September 2020

As at the date of this announcement, the executive Directors are Mr. Shen Shun and Mr. Chen Rongxin; the non-executive Directors are Mr. Zhang Xiongfeng, Mr. Hu Haisong and Mr. Wu Guohua; and the independent non-executive Directors are Mr. Liu Liangzhong and Mr. Lu Yongchao.

Attachments

  • Original document
  • Permalink

Disclaimer

Pa Shun Pharmaceutical International Holdings Ltd. published this content on 02 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 March 2021 04:22:05 UTC.